Literature DB >> 21824101

Synthetic and application perspectives of azapodophyllotoxins: alternative scaffolds of podophyllotoxin.

A Kumar1, V Kumar, A E Alegria, S V Malhotra.   

Abstract

Podophyllotoxin (1) has been known to possess anti-tumor activity and is still considered an important lead for research and development of antineoplastic agents. Derivatives of podophyllotoxin, namely etoposide (2), etopophos (3) and teniposide (4) have been developed and are currently used in clinic for the treatment of a variety of malignancies. These agents are also used in combination therapies with other drugs. Due to the drug resistance developed by cancer cells as well as side effects associated with the use of these agents in clinic, the search for new effective anticancer analogues of podophyllotoxin remains an intense area of research. The structural complexity of podophyllotoxin, arising from the presence of four stereogenic carbons in ring C has restricted most of the structural activity relationship (SAR) studied by derivatization of the parent natural product rather than by de novo multi-step chemical synthesis. These issues provide strong impetus to a search for analogues of 1 with simplified structures, which can be accessible via short synthetic sequences from simple starting materials. Even if such initial compounds might have diminished cytotoxic potencies compared with the parent cyclolignan, the ease of preparation of carefully designed libraries of analogues would lead to more informative SAR studies and expeditious structure optimization. In this regard, during the last two decades considerable efforts have been made to synthesize aza- analogs of podophyllotoxin, i. e. aza-podophyllotoxins, with hetero atoms at different positions of the podophyllotoxin skeleton, while keeping the basic podophyllotoxin structure. Recently, there have been significant efforts towards the convenient synthesis of aza-analogs of 1. The use of multicomponent reactions (MCRs) and the synergies of ultrasound and microwave irradiations have increased the synthetic speed and variety of azapodophyllotoxins which are and will be available to be tested against a diverse population of carcinomas and other diseases. It has been reported that several aza-podophyllotoxins retain a great fraction of the cytotoxicity associated with the parent lignan. This review focuses on the strategies towards synthesis of various aza-podophyllotoxin analogues and their biological activities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21824101      PMCID: PMC3278234          DOI: 10.2174/092986711803414331

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  24 in total

1.  Analysis of etoposide binding to subdomains of human DNA topoisomerase II alpha in the absence of DNA.

Authors:  D Leroy; A V Kajava; C Frei; S M Gasser
Journal:  Biochemistry       Date:  2001-02-13       Impact factor: 3.162

2.  Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry.

Authors:  Miklos Feher; Jonathan M Schmidt
Journal:  J Chem Inf Comput Sci       Date:  2003 Jan-Feb

Review 3.  Natural products as sources of new drugs over the period 1981-2002.

Authors:  David J Newman; Gordon M Cragg; Kenneth M Snader
Journal:  J Nat Prod       Date:  2003-07       Impact factor: 4.050

4.  Regioselective synthesis and in vitro anticancer activity of 4-aza-podophyllotoxin derivatives catalyzed by L-proline.

Authors:  Chunling Shi; Juxian Wang; Hui Chen; Daqing Shi
Journal:  J Comb Chem       Date:  2010-07-12

5.  Design, synthesis, and biological evaluation of the first podophyllotoxin analogues as potential vascular-disrupting agents.

Authors:  Raphaël Labruère; Benoît Gautier; Marlène Testud; Johanne Seguin; Christine Lenoir; Stéphanie Desbène-Finck; Philippe Helissey; Christiane Garbay; Guy G Chabot; Michel Vidal; Sylviane Giorgi-Renault
Journal:  ChemMedChem       Date:  2010-12-03       Impact factor: 3.466

6.  Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.

Authors:  X K Zhu; J Guan; Y Tachibana; K F Bastow; S J Cho; H H Cheng; Y C Cheng; M Gurwith; K H Lee
Journal:  J Med Chem       Date:  1999-07-01       Impact factor: 7.446

7.  Nonenolizable podophyllotoxin derivatives.

Authors:  W J Gensler; C D Murthy; M H Trammell
Journal:  J Med Chem       Date:  1977-05       Impact factor: 7.446

8.  Synthesis of Novel Functionalized 4-Aza-2,3-Didehydropodophyllotoxin Derivatives with Potential Antitumor Activity.

Authors:  Ajay Kumar; Antonio E Alegria
Journal:  J Heterocycl Chem       Date:  2010-11       Impact factor: 2.193

9.  4-Aza-2,3-dehydro-4-deoxypodophyllotoxins: simple aza-podophyllotoxin analogues possessing potent cytotoxicity.

Authors:  Y Hitotsuyanagi; M Fukuyo; K Tsuda; M Kobayashi; A Ozeki; H Itokawa; K Takeya
Journal:  Bioorg Med Chem Lett       Date:  2000-02-21       Impact factor: 2.823

10.  Design and effective synthesis of the first 4-aza-2,3-didehydropodophyllotoxin rigid aminologue: a N-methyl-4-[(3,4,5-trimethoxyphenyl)amino)]-1,2-dihydroquinoline-lactone.

Authors:  Raphaël Labruère; Philippe Helissey; Stéphanie Desbène-Finck; Sylviane Giorgi-Renault
Journal:  J Org Chem       Date:  2008-04-02       Impact factor: 4.354

View more
  4 in total

1.  Azapodophyllotoxin Causes Lymphoma and Kidney Cancer Regression by Disrupting Tubulin and Monoglycerols.

Authors:  Arvin M Gouw; Vineet Kumar; Angel Resendez; Fidelia B Alvina; Natalie S Liu; Katherine Margulis; Ling Tong; Richard N Zare; Sanjay V Malhotra; Dean W Felsher
Journal:  ACS Med Chem Lett       Date:  2022-03-30       Impact factor: 4.632

2.  Meeting Proceedings ICBS2016-Translating the Power of Chemical Biology to Clinical Advances.

Authors:  Yugo Kuriki; Toru Komatsu; Peter D Ycas; Sara K Coulup; Erick J Carlson; William C K Pomerantz
Journal:  ACS Chem Biol       Date:  2017-03-17       Impact factor: 5.100

3.  Novel cis-selective and non-epimerisable C3 hydroxy azapodophyllotoxins targeting microtubules in cancer cells.

Authors:  Sahar Kandil; Jennifer M Wymant; Benson M Kariuki; Arwyn T Jones; Christopher McGuigan; Andrew D Westwell
Journal:  Eur J Med Chem       Date:  2015-12-23       Impact factor: 6.514

4.  Compound A398, a novel podophyllotoxin analogue: cytotoxicity and induction of apoptosis in human leukemia cells.

Authors:  Alethéia L Silveira; Glaúcia V Faheina-Martins; Raquel C Maia; Demetrius A M Araújo
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.